Component
L-Lysine
Free L-enantiomer of lysine, an indispensable proteinogenic amino acid. Separate from protein-bound lysine residues, D-lysine and polylysine.
43 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
The AASS reductase domain condenses lysine with 2-oxoglutarate using NADPH to form saccharopine.
Experimental context and source evidence
- experimental_model
- Recombinant human AASS and isolated reductase domain
- limitations
- Reaction reversibility in vitro does not imply appreciable human lysine biosynthesis.
- organism
- Homo sapiens
- plain_language
- AASS starts the main lysine breakdown route.
- primary_references
- [leandro2022] Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1 (2022). https://pmc.ncbi.nlm.nih.gov/articles/PMC9490328/ DOI: 10.1098/rsob.220179
- tissue_or_cell_type
- Mitochondrial matrix
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 74–82
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human AASS and isolated reductase domain · source_derived_draft · unverified_draft
### aass-reductase The AASS reductase domain condenses lysine with 2-oxoglutarate using NADPH to form saccharopine. Plain language: AASS starts the main lysine breakdown route. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Mitochondrial matrix experimental_model: Recombinant human AASS and isolated reductase domain limitations: Reaction reversibility in vitro does not imply appreciable human lysine biosynthesis. [leandro2022] Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1 (2022). https://pmc.ncbi.nlm.nih.gov/articles/PMC9490328/ DOI: 10.1098/rsob.220179
Complete structured claim and evidenceAdding lysine plus arginine to a low-protein diet produced only a nonsignificant calcium-absorption trend: 25.2% versus 22.3% with control, P=0.094.
Experimental context and source evidence
- experimental_model
- Six-day randomized crossover feeding study in 14 women
- limitations
- Combined amino acids; small sample; specifically low-protein background diet; no long-term skeletal endpoint.
- organism
- Homo sapiens
- plain_language
- The trial did not establish a statistically significant absorption benefit.
- primary_references
- [bihuniak2014] Supplementing a low-protein diet with dibasic amino acids increases urinary calcium excretion in young women (2014). https://pmc.ncbi.nlm.nih.gov/articles/PMC3927545/ DOI: 10.3945/jn.113.185009
- tissue_or_cell_type
- Intestine
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 769–777
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Six-day randomized crossover feeding study in 14 women · source_derived_draft · unverified_draft
### dibasic-calcium-absorption-trend Adding lysine plus arginine to a low-protein diet produced only a nonsignificant calcium-absorption trend: 25.2% versus 22.3% with control, P=0.094. Plain language: The trial did not establish a statistically significant absorption benefit. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Intestine experimental_model: Six-day randomized crossover feeding study in 14 women limitations: Combined amino acids; small sample; specifically low-protein background diet; no long-term skeletal endpoint. [bihuniak2014] Supplementing a low-protein diet with dibasic amino acids increases urinary calcium excretion in young women (2014). https://pmc.ncbi.nlm.nih.gov/articles/PMC3927545/ DOI: 10.3945/jn.113.185009
Complete structured claim and evidenceIn the same crossover study, lysine plus arginine significantly increased urinary calcium compared with the low-protein control diet.
Experimental context and source evidence
- experimental_model
- Randomized crossover feeding trial in 14 women
- limitations
- No lysine-only arm or demonstrated long-term calcium-balance effect.
- organism
- Homo sapiens
- plain_language
- More urinary calcium accompanied the mixture; it cannot by itself be read as either bone loss or better bone health.
- primary_references
- [bihuniak2014] Supplementing a low-protein diet with dibasic amino acids increases urinary calcium excretion in young women (2014). https://pmc.ncbi.nlm.nih.gov/articles/PMC3927545/ DOI: 10.3945/jn.113.185009
- tissue_or_cell_type
- Kidney and urine
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 779–787
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized crossover feeding trial in 14 women · source_derived_draft · unverified_draft
### dibasic-urinary-calcium-increase In the same crossover study, lysine plus arginine significantly increased urinary calcium compared with the low-protein control diet. Plain language: More urinary calcium accompanied the mixture; it cannot by itself be read as either bone loss or better bone health. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Kidney and urine experimental_model: Randomized crossover feeding trial in 14 women limitations: No lysine-only arm or demonstrated long-term calcium-balance effect. [bihuniak2014] Supplementing a low-protein diet with dibasic amino acids increases urinary calcium excretion in young women (2014). https://pmc.ncbi.nlm.nih.gov/articles/PMC3927545/ DOI: 10.3945/jn.113.185009
Complete structured claim and evidenceIn the Pakistani wheat-fortification trial, children receiving lysine-fortified flour gained more height and weight than controls over three months.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- experimental_model
- Double-blind family feeding trial
- limitations
- Predominantly cereal-based, economically constrained diet; not proof of growth enhancement in lysine-replete children or isolated lysine deficiency in every participant.
- organism
- Homo sapiens
- plain_language
- Improving a lysine-poor staple was associated with better child growth in this dietary setting.
- primary_references
- [hussain2004] Lysine fortification of wheat flour improves selected indices of the nutritional status of predominantly cereal-eating families in Pakistan (2004). https://pubmed.ncbi.nlm.nih.gov/15214256/ DOI: 10.1177/156482650402500202
- tissue_or_cell_type
- Whole-body growth
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 659–667
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Double-blind family feeding trial · source_derived_draft · unverified_draft
### fortification-child-growth In the Pakistani wheat-fortification trial, children receiving lysine-fortified flour gained more height and weight than controls over three months. Plain language: Improving a lysine-poor staple was associated with better child growth in this dietary setting. Condition category: nutrient_deficiency organism: Homo sapiens tissue_or_cell_type: Whole-body growth experimental_model: Double-blind family feeding trial limitations: Predominantly cereal-based, economically constrained diet; not proof of growth enhancement in lysine-replete children or isolated lysine deficiency in every participant. [hussain2004] Lysine fortification of wheat flour improves selected indices of the nutritional status of predominantly cereal-eating families in Pakistan (2004). https://pubmed.ncbi.nlm.nih.gov/15214256/ DOI: 10.1177/156482650402500202
Complete structured claim and evidenceThe Ghana trial found no significant lysine-placebo difference in trait-anxiety change or skin-conductance stress responses.
Experimental context and source evidence
- experimental_model
- Randomized placebo-controlled community trial using 1 g/day
- limitations
- Only a subset was at estimated dietary inadequacy risk; within-group improvement does not show treatment efficacy.
- organism
- Homo sapiens
- plain_language
- Questionnaire anxiety improved in both groups, without a lysine-specific difference.
- primary_references
- [ghosh2010] Effect of lysine supplementation on health and morbidity in subjects belonging to poor peri-urban households in Accra, Ghana (2010). https://www.sciencedirect.com/science/article/pii/S0002916523019640 DOI: 10.3945/ajcn.2009.28834
- tissue_or_cell_type
- Behavioral questionnaires and skin conductance
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 709–717
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized placebo-controlled community trial using 1 g/day · source_derived_draft · unverified_draft
### ghana-anxiety-null The Ghana trial found no significant lysine-placebo difference in trait-anxiety change or skin-conductance stress responses. Plain language: Questionnaire anxiety improved in both groups, without a lysine-specific difference. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Behavioral questionnaires and skin conductance experimental_model: Randomized placebo-controlled community trial using 1 g/day limitations: Only a subset was at estimated dietary inadequacy risk; within-group improvement does not show treatment efficacy. [ghosh2010] Effect of lysine supplementation on health and morbidity in subjects belonging to poor peri-urban households in Accra, Ghana (2010). https://www.sciencedirect.com/science/article/pii/S0002916523019640 DOI: 10.3945/ajcn.2009.28834
Complete structured claim and evidenceIn the Ghana trial, lysine supplementation was associated with fewer child diarrheal episodes and illness days than placebo.
Experimental context and source evidence
- experimental_model
- Randomized placebo-controlled community trial
- limitations
- Context-specific clinical result; does not establish receptor antagonism, intestinal repair mechanism, or broad infection prevention.
- organism
- Homo sapiens
- plain_language
- A benefit appeared for this child morbidity endpoint in the studied community.
- primary_references
- [ghosh2010] Effect of lysine supplementation on health and morbidity in subjects belonging to poor peri-urban households in Accra, Ghana (2010). https://www.sciencedirect.com/science/article/pii/S0002916523019640 DOI: 10.3945/ajcn.2009.28834
- tissue_or_cell_type
- Gastrointestinal illness outcomes
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 719–727
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized placebo-controlled community trial · source_derived_draft · unverified_draft
### ghana-child-diarrhea In the Ghana trial, lysine supplementation was associated with fewer child diarrheal episodes and illness days than placebo. Plain language: A benefit appeared for this child morbidity endpoint in the studied community. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Gastrointestinal illness outcomes experimental_model: Randomized placebo-controlled community trial limitations: Context-specific clinical result; does not establish receptor antagonism, intestinal repair mechanism, or broad infection prevention. [ghosh2010] Effect of lysine supplementation on health and morbidity in subjects belonging to poor peri-urban households in Accra, Ghana (2010). https://www.sciencedirect.com/science/article/pii/S0002916523019640 DOI: 10.3945/ajcn.2009.28834
Complete structured claim and evidenceThe 1980 crossover trial found no overall reduction in herpes-labialis recurrence or healing time with 1 g daily lysine, despite more recurrence-free participants.
Experimental context and source evidence
- experimental_model
- Double-blind crossover clinical trial in 65 patients
- limitations
- Twelve-week treatment periods; outcome definition and regimen differ from the later positive trial.
- organism
- Homo sapiens
- plain_language
- The average recurrence and healing results were negative, although one secondary pattern favored treatment.
- primary_references
- [milman1980] Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study. (1980). https://medicaljournalssweden.se/actadv/article/view/10630 DOI: 10.2340/00015555608587
- tissue_or_cell_type
- Lip herpes lesions
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 679–687
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Double-blind crossover clinical trial in 65 patients · source_derived_draft · unverified_draft
### hsv-recurrence-null-trial The 1980 crossover trial found no overall reduction in herpes-labialis recurrence or healing time with 1 g daily lysine, despite more recurrence-free participants. Plain language: The average recurrence and healing results were negative, although one secondary pattern favored treatment. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Lip herpes lesions experimental_model: Double-blind crossover clinical trial in 65 patients limitations: Twelve-week treatment periods; outcome definition and regimen differ from the later positive trial. [milman1980] Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study. (1980). https://medicaljournalssweden.se/actadv/article/view/10630 DOI: 10.2340/00015555608587
Complete structured claim and evidenceThe 1987 trial reported fewer recurrent HSV episodes with lysine than placebo among completers receiving 1 g three times daily for six months.
Experimental context and source evidence
- experimental_model
- Double-blind placebo-controlled multicenter clinical trial
- limitations
- 52 completers; reported symptom/healing findings do not prove direct viral inhibition; intake is a studied regimen, not a recommendation.
- organism
- Homo sapiens
- plain_language
- One small trial favored lysine for recurrence prevention.
- primary_references
- [griffith1987] Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis. (1987). https://pubmed.ncbi.nlm.nih.gov/3115841/ DOI: 10.1159/000248823
- tissue_or_cell_type
- Clinical mucocutaneous HSV outcomes
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 669–677
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Double-blind placebo-controlled multicenter clinical trial · source_derived_draft · unverified_draft
### hsv-recurrence-positive-trial The 1987 trial reported fewer recurrent HSV episodes with lysine than placebo among completers receiving 1 g three times daily for six months. Plain language: One small trial favored lysine for recurrence prevention. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Clinical mucocutaneous HSV outcomes experimental_model: Double-blind placebo-controlled multicenter clinical trial limitations: 52 completers; reported symptom/healing findings do not prove direct viral inhibition; intake is a studied regimen, not a recommendation. [griffith1987] Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis. (1987). https://pubmed.ncbi.nlm.nih.gov/3115841/ DOI: 10.1159/000248823
Complete structured claim and evidenceKARS1 activates lysine with ATP, forming enzyme-bound lysyl-adenylate and releasing pyrophosphate.
Experimental context and source evidence
- experimental_model
- Human LysRS cryo-EM and aminoacylation assays
- limitations
- The structural experiment used tRNA-Lys3; KARS1 is not the leucyl-tRNA synthetase LARS1.
- organism
- Homo sapiens
- plain_language
- ATP activates lysine before it is attached to its carrier RNA.
- primary_references
- [devarkar2025] Structural basis for aminoacylation of cellular modified tRNALys3 by human lysyl-tRNA synthetase (2025). https://pubmed.ncbi.nlm.nih.gov/40036503/ DOI: 10.1093/nar/gkaf114
- tissue_or_cell_type
- Cytosolic tRNA charging
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 54–62
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human LysRS cryo-EM and aminoacylation assays · source_derived_draft · unverified_draft
### lysine-adenylation KARS1 activates lysine with ATP, forming enzyme-bound lysyl-adenylate and releasing pyrophosphate. Plain language: ATP activates lysine before it is attached to its carrier RNA. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Cytosolic tRNA charging experimental_model: Human LysRS cryo-EM and aminoacylation assays limitations: The structural experiment used tRNA-Lys3; KARS1 is not the leucyl-tRNA synthetase LARS1. [devarkar2025] Structural basis for aminoacylation of cellular modified tRNALys3 by human lysyl-tRNA synthetase (2025). https://pubmed.ncbi.nlm.nih.gov/40036503/ DOI: 10.1093/nar/gkaf114
Complete structured claim and evidenceOne week of combined lysine and arginine reduced trait and stress-induced state anxiety in a randomized trial of 108 healthy Japanese adults.
Experimental context and source evidence
- experimental_model
- Randomized double-blind placebo-controlled trial; 2.64 g/day of each amino acid
- limitations
- Short duration; no lysine-only arm; no established treatment effect for diagnosed anxiety disorders.
- organism
- Homo sapiens
- plain_language
- The tested mixture improved anxiety scores; the contribution of lysine alone is unknown.
- primary_references
- [smriga2007] Oral treatment with L-lysine and L-arginine reduces anxiety and basal cortisol levels in healthy humans (2007). https://pubmed.ncbi.nlm.nih.gov/17510493/ DOI: 10.2220/biomedres.28.85
- tissue_or_cell_type
- Behavioral questionnaires
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 729–737
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind placebo-controlled trial; 2.64 g/day of each amino acid · source_derived_draft · unverified_draft
### lysine-arginine-anxiety One week of combined lysine and arginine reduced trait and stress-induced state anxiety in a randomized trial of 108 healthy Japanese adults. Plain language: The tested mixture improved anxiety scores; the contribution of lysine alone is unknown. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Behavioral questionnaires experimental_model: Randomized double-blind placebo-controlled trial; 2.64 g/day of each amino acid limitations: Short duration; no lysine-only arm; no established treatment effect for diagnosed anxiety disorders. [smriga2007] Oral treatment with L-lysine and L-arginine reduces anxiety and basal cortisol levels in healthy humans (2007). https://pubmed.ncbi.nlm.nih.gov/17510493/ DOI: 10.2220/biomedres.28.85
Complete structured claim and evidenceIn 29 high-trait-anxiety participants, lysine plus arginine increased stress-evoked ACTH, cortisol, adrenaline, and noradrenaline responses without changing heart-rate or blood-pressure responses.
Experimental context and source evidence
- experimental_model
- Ten-day randomized trial; 3 g/day of each amino acid, followed by public-speaking stress
- limitations
- Small combination trial; authors' proposed normalization is an interpretation, not a proven lysine-specific mechanism.
- organism
- Homo sapiens
- plain_language
- The mixture did not simply suppress all stress hormones.
- primary_references
- [jezova2005] Subchronic treatment with amino acid mixture of L-lysine and L-arginine modifies neuroendocrine activation during psychosocial stress in subjects with high trait anxiety (2005). https://pubmed.ncbi.nlm.nih.gov/16117182/ DOI: 10.1080/10284150500162937
- tissue_or_cell_type
- Blood stress hormones and cardiovascular measurements
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 739–747
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Ten-day randomized trial; 3 g/day of each amino acid, followed by public-speaking stress · source_derived_draft · unverified_draft
### lysine-arginine-stress-hormones In 29 high-trait-anxiety participants, lysine plus arginine increased stress-evoked ACTH, cortisol, adrenaline, and noradrenaline responses without changing heart-rate or blood-pressure responses. Plain language: The mixture did not simply suppress all stress hormones. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Blood stress hormones and cardiovascular measurements experimental_model: Ten-day randomized trial; 3 g/day of each amino acid, followed by public-speaking stress limitations: Small combination trial; authors' proposed normalization is an interpretation, not a proven lysine-specific mechanism. [jezova2005] Subchronic treatment with amino acid mixture of L-lysine and L-arginine modifies neuroendocrine activation during psychosocial stress in subjects with high trait anxiety (2005). https://pubmed.ncbi.nlm.nih.gov/16117182/ DOI: 10.1080/10284150500162937
Complete structured claim and evidenceIn a short-term study of osteoporotic patients, lysine supplementation increased measured calcium absorption, whereas the valine and tryptophan comparators did not.
Experimental context and source evidence
- experimental_model
- Amino-acid comparator experiment using 800 mg/day in 45 osteoporotic patients
- limitations
- Short-term mineral handling; no fracture prevention or bone-density benefit established.
- organism
- Homo sapiens
- plain_language
- A small experiment found better absorption of calcium.
- primary_references
- [civitelli1992] Dietary L-lysine and calcium metabolism in humans (1992). https://pubmed.ncbi.nlm.nih.gov/1486246/
- tissue_or_cell_type
- Intestine
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 749–757
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Amino-acid comparator experiment using 800 mg/day in 45 osteoporotic patients · source_derived_draft · unverified_draft
### lysine-calcium-intestinal-study In a short-term study of osteoporotic patients, lysine supplementation increased measured calcium absorption, whereas the valine and tryptophan comparators did not. Plain language: A small experiment found better absorption of calcium. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Intestine experimental_model: Amino-acid comparator experiment using 800 mg/day in 45 osteoporotic patients limitations: Short-term mineral handling; no fracture prevention or bone-density benefit established. [civitelli1992] Dietary L-lysine and calcium metabolism in humans (1992). https://pubmed.ncbi.nlm.nih.gov/1486246/
Complete structured claim and evidenceIn healthy women, adding 400 mg lysine to a calcium load blunted the subsequent rise in urinary calcium; this pattern was not reported for the osteoporotic group.
Experimental context and source evidence
- experimental_model
- Acute calcium-load comparison; healthy and osteoporotic women
- limitations
- Acute load response does not establish long-term calcium balance or skeletal outcomes.
- organism
- Homo sapiens
- plain_language
- Lysine altered short-term urinary calcium handling in one subgroup.
- primary_references
- [civitelli1992] Dietary L-lysine and calcium metabolism in humans (1992). https://pubmed.ncbi.nlm.nih.gov/1486246/
- tissue_or_cell_type
- Kidney and urine
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 759–767
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Acute calcium-load comparison; healthy and osteoporotic women · source_derived_draft · unverified_draft
### lysine-calcium-urinary-blunting In healthy women, adding 400 mg lysine to a calcium load blunted the subsequent rise in urinary calcium; this pattern was not reported for the osteoporotic group. Plain language: Lysine altered short-term urinary calcium handling in one subgroup. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Kidney and urine experimental_model: Acute calcium-load comparison; healthy and osteoporotic women limitations: Acute load response does not establish long-term calcium balance or skeletal outcomes. [civitelli1992] Dietary L-lysine and calcium metabolism in humans (1992). https://pubmed.ncbi.nlm.nih.gov/1486246/
Complete structured claim and evidenceIn noncancerous human cell lines, lysine withdrawal rapidly inhibited protein synthesis and stalled cell-cycle progression.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- experimental_model
- Live-cell imaging and perturbation experiments, primarily MCF10A and RPE-hTERT
- limitations
- Cell-line and acute-starvation context; response differs among amino acids and may vary across primary tissues.
- organism
- Homo sapiens
- plain_language
- Removing this required amino acid disrupted protein production and division in cultured cells.
- primary_references
- [rong2023] Cells use multiple mechanisms for cell-cycle arrest upon withdrawal of individual amino acids (2023). https://pmc.ncbi.nlm.nih.gov/articles/PMC11238304/ DOI: 10.1016/j.celrep.2023.113539
- tissue_or_cell_type
- Mammary epithelial and retinal pigment epithelial cell lines
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 829–837
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Live-cell imaging and perturbation experiments, primarily MCF10A and RPE-hTERT · source_derived_draft · unverified_draft
### lysine-deprivation-cellcycle In noncancerous human cell lines, lysine withdrawal rapidly inhibited protein synthesis and stalled cell-cycle progression. Plain language: Removing this required amino acid disrupted protein production and division in cultured cells. Condition category: nutrient_deficiency organism: Homo sapiens tissue_or_cell_type: Mammary epithelial and retinal pigment epithelial cell lines experimental_model: Live-cell imaging and perturbation experiments, primarily MCF10A and RPE-hTERT limitations: Cell-line and acute-starvation context; response differs among amino acids and may vary across primary tissues. [rong2023] Cells use multiple mechanisms for cell-cycle arrest upon withdrawal of individual amino acids (2023). https://pmc.ncbi.nlm.nih.gov/articles/PMC11238304/ DOI: 10.1016/j.celrep.2023.113539
Complete structured claim and evidenceLysine withdrawal suppressed mTORC1 activity in NSCLC cell lines, and lysine restoration reversed the suppression; GCN2 and AMPK contributed to this response.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- experimental_model
- Human NSCLC cell cultures including H1299, H460, and A549
- limitations
- Abrupt medium depletion; no direct lysine-binding sensor established; no supplementation benefit inferred for healthy humans.
- organism
- Homo sapiens
- plain_language
- These cultured cancer cells needed available lysine for full nutrient-and-growth-factor signaling.
- primary_references
- [jang2020] Lysine is required for growth factor-induced mTORC1 activation (2020). https://pubmed.ncbi.nlm.nih.gov/33008594/ DOI: 10.1016/j.bbrc.2020.09.100
- tissue_or_cell_type
- Cultured lung cancer cells
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 819–827
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human NSCLC cell cultures including H1299, H460, and A549 · source_derived_draft · unverified_draft
### lysine-deprivation-mtorc1 Lysine withdrawal suppressed mTORC1 activity in NSCLC cell lines, and lysine restoration reversed the suppression; GCN2 and AMPK contributed to this response. Plain language: These cultured cancer cells needed available lysine for full nutrient-and-growth-factor signaling. Condition category: nutrient_deficiency organism: Homo sapiens tissue_or_cell_type: Cultured lung cancer cells experimental_model: Human NSCLC cell cultures including H1299, H460, and A549 limitations: Abrupt medium depletion; no direct lysine-binding sensor established; no supplementation benefit inferred for healthy humans. [jang2020] Lysine is required for growth factor-induced mTORC1 activation (2020). https://pubmed.ncbi.nlm.nih.gov/33008594/ DOI: 10.1016/j.bbrc.2020.09.100
Complete structured claim and evidenceIn seven men receiving graded lysine intakes, indicator phenylalanine oxidation fell until a breakpoint and then remained approximately constant.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- experimental_model
- Controlled isotope feeding experiment
- limitations
- Small male sample; surrogate measure; plateau is not evidence that extra lysine beyond adequacy builds more muscle.
- organism
- Homo sapiens
- plain_language
- When lysine was limiting, less of another amino acid was retained; providing more lysine changed that metabolic readout up to a plateau.
- primary_references
- [zello1993] Dietary lysine requirement of young adult males determined by oxidation of L-[1-13C]phenylalanine (1993). https://pubmed.ncbi.nlm.nih.gov/8476044/ DOI: 10.1152/ajpendo.1993.264.4.E677
- tissue_or_cell_type
- Whole-body amino-acid metabolism
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 638–646
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Controlled isotope feeding experiment · source_derived_draft · unverified_draft
### lysine-intake-indicator-oxidation In seven men receiving graded lysine intakes, indicator phenylalanine oxidation fell until a breakpoint and then remained approximately constant. Plain language: When lysine was limiting, less of another amino acid was retained; providing more lysine changed that metabolic readout up to a plateau. Condition category: nutrient_deficiency organism: Homo sapiens tissue_or_cell_type: Whole-body amino-acid metabolism experimental_model: Controlled isotope feeding experiment limitations: Small male sample; surrogate measure; plateau is not evidence that extra lysine beyond adequacy builds more muscle. [zello1993] Dietary lysine requirement of young adult males determined by oxidation of L-[1-13C]phenylalanine (1993). https://pubmed.ncbi.nlm.nih.gov/8476044/ DOI: 10.1152/ajpendo.1993.264.4.E677
Complete structured claim and evidenceA single case report associated oral lysine ingestion with Fanconi syndrome, severe tubulointerstitial nephritis, and subsequent chronic renal failure.
Experimental context and source evidence
- experimental_model
- Single clinical case report
- limitations
- No controlled comparison; susceptible individuals, coexposures, causality, and incidence cannot be resolved from this report.
- organism
- Homo sapiens
- plain_language
- This is a safety signal from one patient, not an established frequency or proof of cause.
- primary_references
- [lo1996] Fanconi's syndrome and tubulointerstitial nephritis in association with L-lysine ingestion (1996). https://pubmed.ncbi.nlm.nih.gov/8840955/ DOI: 10.1016/s0272-6386(96)90476-x
- tissue_or_cell_type
- Renal tubules and interstitium
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 789–797
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Single clinical case report · source_derived_draft · unverified_draft
### lysine-renal-case-association A single case report associated oral lysine ingestion with Fanconi syndrome, severe tubulointerstitial nephritis, and subsequent chronic renal failure. Plain language: This is a safety signal from one patient, not an established frequency or proof of cause. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Renal tubules and interstitium experimental_model: Single clinical case report limitations: No controlled comparison; susceptible individuals, coexposures, causality, and incidence cannot be resolved from this report. [lo1996] Fanconi's syndrome and tubulointerstitial nephritis in association with L-lysine ingestion (1996). https://pubmed.ncbi.nlm.nih.gov/8840955/ DOI: 10.1016/s0272-6386(96)90476-x
Complete structured claim and evidenceIn the Syrian trial, lysine fortification reduced the cortisol response associated with blood drawing in females, without the same effect in males.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- experimental_model
- Randomized household fortification trial
- limitations
- Prestress baseline cortisol was not measured; not evidence of universal cortisol lowering.
- organism
- Homo sapiens
- plain_language
- The measured response to a specific stressor differed by sex.
- primary_references
- [smriga2004] Lysine fortification reduces anxiety and lessens stress in family members in economically weak communities in Northwest Syria (2004). https://pmc.ncbi.nlm.nih.gov/articles/PMC420386/ DOI: 10.1073/pnas.0402550101
- tissue_or_cell_type
- Blood cortisol under venipuncture stress
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 699–707
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized household fortification trial · source_derived_draft · unverified_draft
### syria-stress-cortisol In the Syrian trial, lysine fortification reduced the cortisol response associated with blood drawing in females, without the same effect in males. Plain language: The measured response to a specific stressor differed by sex. Condition category: nutrient_deficiency organism: Homo sapiens tissue_or_cell_type: Blood cortisol under venipuncture stress experimental_model: Randomized household fortification trial limitations: Prestress baseline cortisol was not measured; not evidence of universal cortisol lowering. [smriga2004] Lysine fortification reduces anxiety and lessens stress in family members in economically weak communities in Northwest Syria (2004). https://pmc.ncbi.nlm.nih.gov/articles/PMC420386/ DOI: 10.1073/pnas.0402550101
Complete structured claim and evidenceSyrian wheat fortification reduced trait-anxiety scores in men, with benefit concentrated in those with high baseline anxiety; women showed no trait-anxiety effect.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- experimental_model
- Three-month randomized household trial
- limitations
- Dietary estimates, not individual biochemical diagnosis; one questionnaire; cannot establish treatment of anxiety disorders.
- organism
- Homo sapiens
- plain_language
- The anxiety result was subgroup-specific in a population with probable dietary inadequacy.
- primary_references
- [smriga2004] Lysine fortification reduces anxiety and lessens stress in family members in economically weak communities in Northwest Syria (2004). https://pmc.ncbi.nlm.nih.gov/articles/PMC420386/ DOI: 10.1073/pnas.0402550101
- tissue_or_cell_type
- Behavioral questionnaire outcome
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 689–697
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Three-month randomized household trial · source_derived_draft · unverified_draft
### syria-trait-anxiety Syrian wheat fortification reduced trait-anxiety scores in men, with benefit concentrated in those with high baseline anxiety; women showed no trait-anxiety effect. Plain language: The anxiety result was subgroup-specific in a population with probable dietary inadequacy. Condition category: nutrient_deficiency organism: Homo sapiens tissue_or_cell_type: Behavioral questionnaire outcome experimental_model: Three-month randomized household trial limitations: Dietary estimates, not individual biochemical diagnosis; one questionnaire; cannot establish treatment of anxiety disorders. [smriga2004] Lysine fortification reduces anxiety and lessens stress in family members in economically weak communities in Northwest Syria (2004). https://pmc.ncbi.nlm.nih.gov/articles/PMC420386/ DOI: 10.1073/pnas.0402550101
Complete structured claim and evidenceThe tested whole-wheat bread supplied lysine with an estimated 90% metabolic availability, while low lysine concentration still limited its protein quality.
Experimental context and source evidence
- experimental_model
- Randomized intake-order repeated-measures experiment in five young men
- exposure
- Lysine supplied by the tested whole-wheat bread; bread is a food matrix recorded in context, not a chemical-species entity.
- limitations
- Specific bread and small sample; metabolic availability is method-dependent and does not establish adequacy of all wheat-based diets.
- organism
- Homo sapiens
- plain_language
- A food can deliver most of its lysine efficiently yet contain too little lysine relative to other amino acids.
- primary_references
- [tulnoor2025] Lysine from Whole Wheat Bread Consumed by Healthy Adult Males Has High Metabolic Availability When Assessed Using the Indicator Amino Acid Oxidation Method (2025). https://pubmed.ncbi.nlm.nih.gov/39163973/ DOI: 10.1016/j.tjnut.2024.08.011
- tissue_or_cell_type
- Whole-body amino-acid metabolism
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 648–657
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized intake-order repeated-measures experiment in five young men · source_derived_draft · unverified_draft
### wholewheat-lysine-availability The tested whole-wheat bread supplied lysine with an estimated 90% metabolic availability, while low lysine concentration still limited its protein quality. Plain language: A food can deliver most of its lysine efficiently yet contain too little lysine relative to other amino acids. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Whole-body amino-acid metabolism experimental_model: Randomized intake-order repeated-measures experiment in five young men limitations: Specific bread and small sample; metabolic availability is method-dependent and does not establish adequacy of all wheat-based diets. exposure: Lysine supplied by the tested whole-wheat bread; bread is a food matrix recorded in context, not a chemical-species entity. [tulnoor2025] Lysine from Whole Wheat Bread Consumed by Healthy Adult Males Has High Metabolic Availability When Assessed Using the Indicator Amino Acid Oxidation Method (2025). https://pubmed.ncbi.nlm.nih.gov/39163973/ DOI: 10.1016/j.tjnut.2024.08.011
Complete structured claim and evidence
What acts on it
SLC7A9 associated with SLC3A1 mediates sodium-independent lysine exchange at the apical epithelial membrane.
Experimental context and source evidence
- experimental_model
- Human/mouse cloning, Xenopus transport and renal localization
- limitations
- Leucine is an example exchange substrate, not the obligatory unique counter-substrate.
- organism
- Human and mouse proteins; Xenopus expression system
- plain_language
- This transporter admits lysine at the gut or kidney lumen-facing surface.
- primary_references
- [pfeiffer1999b0] Luminal Heterodimeric Amino Acid Transporter Defective in Cystinuria (1999). https://pmc.ncbi.nlm.nih.gov/articles/PMC25748/ DOI: 10.1091/mbc.10.12.4135
- tissue_or_cell_type
- Renal proximal-tubule brush border; intestinal apical context
- transport_effect
- depends The record names sodium-independent lysine exchange and not which way lysine moves in it.
- transport_pool
- the enterocyte interior across the apical membrane The record names sodium-independent lysine exchange and not which way lysine moves in it.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 24–32
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human/mouse cloning, Xenopus transport and renal localization · source_derived_draft · unverified_draft
### apical-lysine-exchange SLC7A9 associated with SLC3A1 mediates sodium-independent lysine exchange at the apical epithelial membrane. Plain language: This transporter admits lysine at the gut or kidney lumen-facing surface. Condition category: normal organism: Human and mouse proteins; Xenopus expression system tissue_or_cell_type: Renal proximal-tubule brush border; intestinal apical context experimental_model: Human/mouse cloning, Xenopus transport and renal localization limitations: Leucine is an example exchange substrate, not the obligatory unique counter-substrate. [pfeiffer1999b0] Luminal Heterodimeric Amino Acid Transporter Defective in Cystinuria (1999). https://pmc.ncbi.nlm.nih.gov/articles/PMC25748/ DOI: 10.1091/mbc.10.12.4135
Complete structured claim and evidenceE. coli CadA converts lysine to cadaverine and CO2 while consuming a proton during acid stress.
Experimental context and source evidence
- experimental_model
- E. coli inducible lysine decarboxylase structural and acid-stress experiments.
- limitations
- Bacterial pathway. Cadaverine exposure or health effects in a human cannot be inferred from this culture mechanism.
- organism
- Escherichia coli
- plain_language
- Some bacteria use lysine to buffer acidic conditions.
- primary_references
- [cada-2011] Linkage between the bacterial acid stress and stringent responses: the structure of the inducible lysine decarboxylase (2011). https://pubmed.ncbi.nlm.nih.gov/21278708/ DOI: 10.1038/emboj.2011.5
- tissue_or_cell_type
- Not specified as a whole tissue; see experimental model.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 618–626
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · E. coli inducible lysine decarboxylase structural and acid-stress experiments. · source_derived_draft · unverified_draft
### bacterial-cada-decarboxylation E. coli CadA converts lysine to cadaverine and CO2 while consuming a proton during acid stress. Plain language: Some bacteria use lysine to buffer acidic conditions. Condition category: normal organism: Escherichia coli tissue_or_cell_type: Not specified as a whole tissue; see experimental model. experimental_model: E. coli inducible lysine decarboxylase structural and acid-stress experiments. limitations: Bacterial pathway. Cadaverine exposure or health effects in a human cannot be inferred from this culture mechanism. [cada-2011] Linkage between the bacterial acid stress and stringent responses: the structure of the inducible lysine decarboxylase (2011). https://pubmed.ncbi.nlm.nih.gov/21278708/ DOI: 10.1038/emboj.2011.5
Complete structured claim and evidenceSLC7A7-SLC3A2 exchanges intracellular cationic amino acids including lysine for extracellular neutral amino acids with sodium.
Experimental context and source evidence
- experimental_model
- Human/mouse heterodimer expression and exchange assays
- limitations
- Neutral-substrate transport is sodium-dependent; lysine binding itself should not be mislabeled a sodium cotransport step.
- organism
- Homo sapiens
- plain_language
- This route helps lysine leave epithelial cells toward blood.
- primary_references
- [pfeiffer1999yl] Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family. (1999). https://pubmed.ncbi.nlm.nih.gov/9878049/ DOI: 10.1093/emboj/18.1.49
- tissue_or_cell_type
- Basolateral intestinal and renal epithelial membranes
- transport_effect
- lowers Exchanges intracellular cationic amino acids including lysine for extracellular neutral amino acids, so lysine leaves the cell.
- transport_pool
- the enterocyte interior Exchanges intracellular cationic amino acids including lysine for extracellular neutral amino acids, so lysine leaves the cell.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 34–42
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human/mouse heterodimer expression and exchange assays · source_derived_draft · unverified_draft
### basolateral-lysine-exchange SLC7A7-SLC3A2 exchanges intracellular cationic amino acids including lysine for extracellular neutral amino acids with sodium. Plain language: This route helps lysine leave epithelial cells toward blood. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Basolateral intestinal and renal epithelial membranes experimental_model: Human/mouse heterodimer expression and exchange assays limitations: Neutral-substrate transport is sodium-dependent; lysine binding itself should not be mislabeled a sodium cotransport step. [pfeiffer1999yl] Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family. (1999). https://pubmed.ncbi.nlm.nih.gov/9878049/ DOI: 10.1093/emboj/18.1.49
Complete structured claim and evidenceHuman CAT1 transports L-lysine across the plasma membrane.
Experimental context and source evidence
- experimental_model
- Human CAT1 expressed in Xenopus oocytes
- limitations
- Transporter expression assay; the relative contribution varies by tissue.
- organism
- Homo sapiens
- plain_language
- CAT1 moves free lysine across cell membranes.
- primary_references
- [furesz2002] Lysine uptake by cloned hCAT-2B: comparison with hCAT-1 and with trophoblast surface membranes. (2002). https://pubmed.ncbi.nlm.nih.gov/12202949/ DOI: 10.1007/s00232-002-1001-0
- tissue_or_cell_type
- Plasma membrane; compared with placental trophoblast membranes
- transport_effect
- depends The record names the membrane lysine crosses and not which way it crosses it.
- transport_pool
- the cytosol across the plasma membrane The record names the membrane lysine crosses and not which way it crosses it.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 14–22
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human CAT1 expressed in Xenopus oocytes · source_derived_draft · unverified_draft
### cat1-lysine-transport Human CAT1 transports L-lysine across the plasma membrane. Plain language: CAT1 moves free lysine across cell membranes. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Plasma membrane; compared with placental trophoblast membranes experimental_model: Human CAT1 expressed in Xenopus oocytes limitations: Transporter expression assay; the relative contribution varies by tissue. [furesz2002] Lysine uptake by cloned hCAT-2B: comparison with hCAT-1 and with trophoblast surface membranes. (2002). https://pubmed.ncbi.nlm.nih.gov/12202949/ DOI: 10.1007/s00232-002-1001-0
Complete structured claim and evidenceReconstituted human SLC25A29 transports lysine by uniport and exchange, supporting lysine entry into the mitochondrial matrix.
Experimental context and source evidence
- experimental_model
- Purified recombinant carrier reconstituted in liposomes
- limitations
- Physiological import role is inferred from transport properties and localization; not a carnitine transporter.
- organism
- Homo sapiens
- plain_language
- SLC25A29 gives lysine access to mitochondrial metabolism.
- primary_references
- [porcelli2014] The Human Gene SLC25A29, of Solute Carrier Family 25, Encodes a Mitochondrial Transporter of Basic Amino Acids (2014). https://pmc.ncbi.nlm.nih.gov/articles/PMC4036346/ DOI: 10.1074/jbc.M114.547448
- tissue_or_cell_type
- Inner mitochondrial membrane
- transport_effect
- raises Uniport and exchange supporting lysine entry into the matrix.
- transport_pool
- the mitochondrial matrix Uniport and exchange supporting lysine entry into the matrix.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 44–52
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified recombinant carrier reconstituted in liposomes · source_derived_draft · unverified_draft
### mitochondrial-lysine-transport Reconstituted human SLC25A29 transports lysine by uniport and exchange, supporting lysine entry into the mitochondrial matrix. Plain language: SLC25A29 gives lysine access to mitochondrial metabolism. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Inner mitochondrial membrane experimental_model: Purified recombinant carrier reconstituted in liposomes limitations: Physiological import role is inferred from transport properties and localization; not a carnitine transporter. [porcelli2014] The Human Gene SLC25A29, of Solute Carrier Family 25, Encodes a Mitochondrial Transporter of Basic Amino Acids (2014). https://pmc.ncbi.nlm.nih.gov/articles/PMC4036346/ DOI: 10.1074/jbc.M114.547448
Complete structured claim and evidence
Where it participates (unsigned role)
Biotinidase releases biotin from its linkage to the epsilon-amino group of lysine, allowing the cofactor to be reused.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/biotin-research/6883721.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0f881dd651d45537377661fc515239c3babb7160c3dbd53b8b0611ba33625aaa", "start_char": 0, "end_char": 1500, "text_sha256": "0f881dd651d45537377661fc515239c3babb7160c3dbd53b8b0611ba33625aaa"}
- experimental_model
- Serum enzyme assays in 5 children with late-onset multiple carboxylase deficiency and family members
- exposure
- Inherited deficiency; patient/control comparison
- limitations
- Early small case series; the serum enzyme phenotype is genetic machinery impairment, not proof of low dietary intake.
- nutrient_topic
- Biotin research collection; topical membership is not evidence of a direct dietary effect. · Biotin
- organism
- Homo sapiens
- plain_language
- Biotinidase recovers biotin after biotin-containing material is broken down.
- primary_references
- [b7-p6883721] Biotinidase deficiency: the enzymatic defect in late-onset multiple carboxylase deficiency. (1983). https://pubmed.ncbi.nlm.nih.gov/6883721/ DOI: 10.1016/0009-8981(83)90096-7
- tissue_or_cell_type
- Serum and biochemical disease phenotype
Biotin: carboxylases, recycling, deficiency and nutrient interactions (2026-09-17) · lines 455–466
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Serum enzyme assays in 5 children with late-onset multiple carboxylase deficiency and family members · source_derived_draft · unverified_draft
### b7-btd-recycling Biotinidase releases biotin from its linkage to the epsilon-amino group of lysine, allowing the cofactor to be reused. Condition category: normal nutrient_topic: Biotin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Biotinidase recovers biotin after biotin-containing material is broken down. organism: Homo sapiens tissue_or_cell_type: Serum and biochemical disease phenotype experimental_model: Serum enzyme assays in 5 children with late-onset multiple carboxylase deficiency and family members limitations: Early small case series; the serum enzyme phenotype is genetic machinery impairment, not proof of low dietary intake. exposure: Inherited deficiency; patient/control comparison evidence_span: {"source_cache": "artifacts/biotin-research/6883721.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0f881dd651d45537377661fc515239c3babb7160c3dbd53b8b0611ba33625aaa", "start_char": 0, "end_char": 1500, "text_sha256": "0f881dd651d45537377661fc515239c3babb7160c3dbd53b8b0611ba33625aaa"} [b7-p6883721] Biotinidase deficiency: the enzymatic defect in late-onset multiple carboxylase deficiency. (1983). https://pubmed.ncbi.nlm.nih.gov/6883721/ DOI: 10.1016/0009-8981(83)90096-7
Complete structured claim and evidenceThe antiquitin defect was linked to accumulation of alpha-AASA/P6C in the lysine degradation pathway.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- cross_nutrient
- Lysine catabolism generates the metabolite that can sequester PLP.
- experimental_model
- Affected children, expressed human ALDH7A1 variants and metabolite chemistry
- exposure
- ALDH7A1-associated disease and metabolite analysis.
- limitations
- This is inherited pathway failure, not lysine toxicity in healthy people.
- nutrient_topic
- Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B6
- organism
- Homo sapiens
- plain_language
- A blocked lysine pathway builds up B6-reactive metabolites.
- primary_references
- [mills-2006-aldh7a1] Mutations in antiquitin in individuals with pyridoxine-dependent seizures (2006). https://doi.org/10.1038/nm1366 DOI: 10.1038/nm1366
- tissue_or_cell_type
- Patient biological samples and biochemical pathway analysis
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Vitamin B6: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1158–1169
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Affected children, expressed human ALDH7A1 variants and metabolite chemistry · source_derived_draft · unverified_draft
### b6-neuro-aldh7a1-metabolite-accumulation The antiquitin defect was linked to accumulation of alpha-AASA/P6C in the lysine degradation pathway. Condition category: machinery_impairment nutrient_topic: Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. plain_language: A blocked lysine pathway builds up B6-reactive metabolites. organism: Homo sapiens tissue_or_cell_type: Patient biological samples and biochemical pathway analysis experimental_model: Affected children, expressed human ALDH7A1 variants and metabolite chemistry limitations: This is inherited pathway failure, not lysine toxicity in healthy people. exposure: ALDH7A1-associated disease and metabolite analysis. cross_nutrient: Lysine catabolism generates the metabolite that can sequester PLP. [mills-2006-aldh7a1] Mutations in antiquitin in individuals with pyridoxine-dependent seizures (2006). https://doi.org/10.1038/nm1366 DOI: 10.1038/nm1366
Complete structured claim and evidencePatient DHTKD1-deficient fibroblasts accumulated deuterium-labeled 2-oxoadipate from labeled lysine; wild-type DHTKD1 expression normalized the biochemical defect.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- cross_nutrient
- A B1-dependent enzyme connects lysine degradation to glutaryl-CoA metabolism.
- evidence
- [{"paper_key": "danhauser-2012-dhtkd1", "source_bundle": "artifacts/thiamine_metabolism_sources.json", "passage_ids": ["abstract"], "locator": "Primary publication abstract", "preservation": "Exact text retained in the source bundle; full source document retained when openly retrievable."}]
- experimental_model
- Patient fibroblasts, isotope tracing and lentiviral complementation.
- limitations
- Two individuals; neurological phenotypes vary and biochemical rescue does not prove a clinical treatment.
- nutrient
- Thiamine (vitamin B1) · Thiamine (vitamin B1)
- nutrient_topic
- Thiamine research collection; topical membership is not evidence of a direct dietary effect. · Thiamine (vitamin B1)
- organism
- Homo sapiens
- plain_language
- Replacing the faulty enzyme restored the tested metabolic step. The experiment identifies a machinery defect rather than a lack of dietary B1.
- primary_references
- [danhauser-2012-dhtkd1] DHTKD1 mutations cause 2-aminoadipic and 2-oxoadipic aciduria (2012). https://pubmed.ncbi.nlm.nih.gov/23141293/ DOI: 10.1016/j.ajhg.2012.10.006
- tissue_or_cell_type
- Cultured fibroblasts
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Thiamine: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 909–921
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Patient fibroblasts, isotope tracing and lentiviral complementation. · source_derived_draft · unverified_draft
### b1-dhtkd1-patient-lysine-turnover Patient DHTKD1-deficient fibroblasts accumulated deuterium-labeled 2-oxoadipate from labeled lysine; wild-type DHTKD1 expression normalized the biochemical defect. Condition category: machinery_impairment nutrient_topic: Thiamine research collection; topical membership is not evidence of a direct dietary effect. plain_language: Replacing the faulty enzyme restored the tested metabolic step. The experiment identifies a machinery defect rather than a lack of dietary B1. organism: Homo sapiens tissue_or_cell_type: Cultured fibroblasts experimental_model: Patient fibroblasts, isotope tracing and lentiviral complementation. limitations: Two individuals; neurological phenotypes vary and biochemical rescue does not prove a clinical treatment. evidence: [{"paper_key": "danhauser-2012-dhtkd1", "source_bundle": "artifacts/thiamine_metabolism_sources.json", "passage_ids": ["abstract"], "locator": "Primary publication abstract", "preservation": "Exact text retained in the source bundle; full source document retained when openly retrievable."}] cross_nutrient: A B1-dependent enzyme connects lysine degradation to glutaryl-CoA metabolism. nutrient: Thiamine (vitamin B1) [danhauser-2012-dhtkd1] DHTKD1 mutations cause 2-aminoadipic and 2-oxoadipic aciduria (2012). https://pubmed.ncbi.nlm.nih.gov/23141293/ DOI: 10.1016/j.ajhg.2012.10.006
Complete structured claim and evidenceHuman DHTKD1 supported 2-oxoadipate dehydrogenase activity when combined with the DLST and DLD components also used by OGDH.
Experimental context and source evidence
- cross_nutrient
- B1-dependent lysine catabolism converges on the same lipoyl, CoA and NAD/FAD machinery used in OGDH.
- evidence
- [{"paper_key": "nemeria-2018-oadh", "source_bundle": "artifacts/thiamine_metabolism_sources.json", "passage_ids": ["abstract"], "locator": "Primary publication abstract", "preservation": "Exact text retained in the source bundle; full source document retained when openly retrievable."}]
- experimental_model
- Human recombinant component reconstitution.
- limitations
- Reconstituted proteins; sharing does not establish competition for limiting subunits in vivo.
- nutrient
- Thiamine (vitamin B1) · Thiamine (vitamin B1)
- nutrient_topic
- Thiamine research collection; topical membership is not evidence of a direct dietary effect. · Thiamine (vitamin B1)
- organism
- Homo sapiens
- plain_language
- Lysine-related carbon disposal uses a different B1-dependent E1, while sharing the downstream E2 and E3 proteins with a TCA-cycle enzyme.
- primary_references
- [nemeria-2018-oadh] The mitochondrial 2-oxoadipate and 2-oxoglutarate dehydrogenase complexes share their E2 and E3 components for their function and both generate reactive oxygen species (2018). https://pubmed.ncbi.nlm.nih.gov/29191460/ DOI: 10.1016/j.freeradbiomed.2017.11.018
- tissue_or_cell_type
- Purified complex
Thiamine: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 869–881
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human recombinant component reconstitution. · source_derived_draft · unverified_draft
### b1-dhtkd1-recruits-shared-dlst-dld Human DHTKD1 supported 2-oxoadipate dehydrogenase activity when combined with the DLST and DLD components also used by OGDH. Condition category: normal nutrient_topic: Thiamine research collection; topical membership is not evidence of a direct dietary effect. plain_language: Lysine-related carbon disposal uses a different B1-dependent E1, while sharing the downstream E2 and E3 proteins with a TCA-cycle enzyme. organism: Homo sapiens tissue_or_cell_type: Purified complex experimental_model: Human recombinant component reconstitution. limitations: Reconstituted proteins; sharing does not establish competition for limiting subunits in vivo. evidence: [{"paper_key": "nemeria-2018-oadh", "source_bundle": "artifacts/thiamine_metabolism_sources.json", "passage_ids": ["abstract"], "locator": "Primary publication abstract", "preservation": "Exact text retained in the source bundle; full source document retained when openly retrievable."}] cross_nutrient: B1-dependent lysine catabolism converges on the same lipoyl, CoA and NAD/FAD machinery used in OGDH. nutrient: Thiamine (vitamin B1) [nemeria-2018-oadh] The mitochondrial 2-oxoadipate and 2-oxoglutarate dehydrogenase complexes share their E2 and E3 components for their function and both generate reactive oxygen species (2018). https://pubmed.ncbi.nlm.nih.gov/29191460/ DOI: 10.1016/j.freeradbiomed.2017.11.018
Complete structured claim and evidenceGlutaryl-CoA inhibited human OGDH activity in reconstituted experiments, supporting possible regulatory communication from OADH-linked amino-acid degradation to the TCA cycle.
Experimental context and source evidence
- cross_nutrient
- Amino-acid catabolism and central carbon metabolism communicate through an acyl-CoA product.
- evidence
- [{"paper_key": "nemeria-2018-crosstalk", "source_bundle": "artifacts/thiamine_metabolism_sources.json", "passage_ids": ["abstract"], "locator": "Primary publication abstract", "preservation": "Exact text retained in the source bundle; full source document retained when openly retrievable."}]
- experimental_model
- Reconstituted human enzyme inhibition assays.
- limitations
- In vitro regulation; physiological free metabolite concentrations and net in vivo effect were not established.
- nutrient
- Thiamine (vitamin B1) · Thiamine (vitamin B1)
- nutrient_topic
- Thiamine research collection; topical membership is not evidence of a direct dietary effect. · Thiamine (vitamin B1)
- organism
- Homo sapiens
- plain_language
- A product of one B1-dependent route can restrain a different B1 enzyme in a test tube. Its importance inside tissues remains unquantified.
- primary_references
- [nemeria-2018-crosstalk] Evidence for functional and regulatory cross-talk between the tricarboxylic acid cycle 2-oxoglutarate dehydrogenase complex and 2-oxoadipate dehydrogenase on the l-lysine, l-hydroxylysine and l-tryptophan degradation pathways from studies in vitro (2018). https://pubmed.ncbi.nlm.nih.gov/29752936/ DOI: 10.1016/j.bbabio.2018.05.001
- tissue_or_cell_type
- Purified complexes
Thiamine: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 936–948
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Reconstituted human enzyme inhibition assays. · source_derived_draft · unverified_draft
### b1-lysine-product-inhibits-ogdh Glutaryl-CoA inhibited human OGDH activity in reconstituted experiments, supporting possible regulatory communication from OADH-linked amino-acid degradation to the TCA cycle. Condition category: normal nutrient_topic: Thiamine research collection; topical membership is not evidence of a direct dietary effect. plain_language: A product of one B1-dependent route can restrain a different B1 enzyme in a test tube. Its importance inside tissues remains unquantified. organism: Homo sapiens tissue_or_cell_type: Purified complexes experimental_model: Reconstituted human enzyme inhibition assays. limitations: In vitro regulation; physiological free metabolite concentrations and net in vivo effect were not established. evidence: [{"paper_key": "nemeria-2018-crosstalk", "source_bundle": "artifacts/thiamine_metabolism_sources.json", "passage_ids": ["abstract"], "locator": "Primary publication abstract", "preservation": "Exact text retained in the source bundle; full source document retained when openly retrievable."}] cross_nutrient: Amino-acid catabolism and central carbon metabolism communicate through an acyl-CoA product. nutrient: Thiamine (vitamin B1) [nemeria-2018-crosstalk] Evidence for functional and regulatory cross-talk between the tricarboxylic acid cycle 2-oxoglutarate dehydrogenase complex and 2-oxoadipate dehydrogenase on the l-lysine, l-hydroxylysine and l-tryptophan degradation pathways from studies in vitro (2018). https://pubmed.ncbi.nlm.nih.gov/29752936/ DOI: 10.1016/j.bbabio.2018.05.001
Complete structured claim and evidenceIncreasing medium glycine from the millimolar range increased type-II collagen production in cultured bovine chondrocytes, with larger sustained effects than the tested proline/lysine increments.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Bovine articular chondrocyte monolayers; 15-day concentration series and collagen ELISA.
- limitations
- The paper proposes dietary implications, but the experiment does not establish human glycine essentiality, osteoarthritis causation or cartilage regeneration.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Collagen-producing cells responded to extra glycine in a culture assay.
- primary_references
- High glycine concentration increases collagen synthesis by articular chondrocytes in vitro: acute glycine deficiency could be an important cause of osteoarthritis. · 2018 · https://pubmed.ncbi.nlm.nih.gov/30006659/ · DOI 10.1007/s00726-018-2611-x
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 402–408
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Bovine articular chondrocyte monolayers; 15-day concentration series and collagen ELISA. · source_derived_draft · unverified_draft
## glycine-collagen-culture Collagen-producing cells responded to extra glycine in a culture assay. Increasing medium glycine from the millimolar range increased type-II collagen production in cultured bovine chondrocytes, with larger sustained effects than the tested proline/lysine increments. Model: Bovine articular chondrocyte monolayers; 15-day concentration series and collagen ELISA. Limitations: The paper proposes dietary implications, but the experiment does not establish human glycine essentiality, osteoarthritis causation or cartilage regeneration. Evidence access: Primary full text High glycine concentration increases collagen synthesis by articular chondrocytes in vitro: acute glycine deficiency could be an important cause of osteoarthritis. · 2018 · https://pubmed.ncbi.nlm.nih.gov/30006659/ · DOI 10.1007/s00726-018-2611-x
Complete structured claim and evidenceGCN2-deficient mouse CD8 T cells still failed to proliferate under limiting tryptophan, arginine, leucine, lysine or asparagine in the 2016 study.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Gcn2-deficient mice crossed to TCR-transgenic backgrounds; defined amino-acid limitation.
- limitations
- Not identical to every IDO-dendritic-cell preparation; the authors explicitly challenge the earlier necessity model.
- nutrient_topic
- Tryptophan collection; molecular form, preparation, species, exposure and manipulation remain explicit. · L-Tryptophan
- plain_language
- Another study found the division block persisted without that sensor.
- primary_references
- Stress Kinase GCN2 Controls the Proliferative Fitness and Trafficking of Cytotoxic T Cells Independent of Environmental Amino Acid Sensing. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27880901/ · DOI 10.1016/j.celrep.2016.10.079
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Tryptophan: transport, protein synthesis, neuroactive metabolites, NAD and microbial pathways (2026-09-19) · lines 378–384
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Gcn2-deficient mice crossed to TCR-transgenic backgrounds; defined amino-acid limitation. · source_derived_draft · unverified_draft
## tryptophan-gcn2-not-required Another study found the division block persisted without that sensor. GCN2-deficient mouse CD8 T cells still failed to proliferate under limiting tryptophan, arginine, leucine, lysine or asparagine in the 2016 study. Model: Gcn2-deficient mice crossed to TCR-transgenic backgrounds; defined amino-acid limitation. Limitations: Not identical to every IDO-dendritic-cell preparation; the authors explicitly challenge the earlier necessity model. Evidence access: Primary abstract Stress Kinase GCN2 Controls the Proliferative Fitness and Trafficking of Cytotoxic T Cells Independent of Environmental Amino Acid Sensing. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27880901/ · DOI 10.1016/j.celrep.2016.10.079
Complete structured claim and evidenceOSGEPL1 deletion in HEK293T cells reduced aminoacylation of mitochondrial tRNA Thr and tRNA Lys and altered other tRNA modifications.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Human HEK293T knockout and tRNA modification/aminoacylation measurements.
- limitations
- The result identifies a tRNA-modification requirement, not a dietary lysine shortage.
- nutrient_topic
- L-Threonine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Threonine
- plain_language
- Threonine-derived chemistry supports the handling of another amino acid too.
- primary_references
- Multifaceted roles of t6A biogenesis in efficiency and fidelity of mitochondrial gene expression. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38227555/ · DOI 10.1093/nar/gkae013
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Threonine: translation, intestinal barrier, metabolism and cross-nutrient mechanisms (2026-09-19) · lines 154–160
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human HEK293T knockout and tRNA modification/aminoacylation measurements. · source_derived_draft · unverified_draft
## l-threonine-osgepl1-charging Threonine-derived chemistry supports the handling of another amino acid too. OSGEPL1 deletion in HEK293T cells reduced aminoacylation of mitochondrial tRNA Thr and tRNA Lys and altered other tRNA modifications. Model: Human HEK293T knockout and tRNA modification/aminoacylation measurements. Limitations: The result identifies a tRNA-modification requirement, not a dietary lysine shortage. Evidence access: Primary abstract Multifaceted roles of t6A biogenesis in efficiency and fidelity of mitochondrial gene expression. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38227555/ · DOI 10.1093/nar/gkae013
Complete structured claim and evidenceHuman SLC7A9 and SLC3A1 form the b0,+AT–rBAT obligatory exchanger for cystine/cationic amino-acid influx coupled to neutral amino-acid efflux.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human transporter cryo-EM and functional study; structural ligand was arginine.
- limitations
- Do not describe the arginine-bound structure as a captured cystine-bound state or infer dietary competition from binding alone.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- The kidney and intestine use a two-protein exchange system to handle cystine.
- primary_references
- Cryo-EM structure of the human heteromeric amino acid transporter b0,+AT-rBAT. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32494597/ · DOI 10.1126/sciadv.aay6379
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 20–26
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human transporter cryo-EM and functional study; structural ligand was arginine. · source_derived_draft · unverified_draft
## l-cysteine-renal-cystine-exchange The kidney and intestine use a two-protein exchange system to handle cystine. Human SLC7A9 and SLC3A1 form the b0,+AT–rBAT obligatory exchanger for cystine/cationic amino-acid influx coupled to neutral amino-acid efflux. Model: Human transporter cryo-EM and functional study; structural ligand was arginine. Limitations: Do not describe the arginine-bound structure as a captured cystine-bound state or infer dietary competition from binding alone. Evidence access: Primary full text Cryo-EM structure of the human heteromeric amino acid transporter b0,+AT-rBAT. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32494597/ · DOI 10.1126/sciadv.aay6379
Complete structured claim and evidenceCitrulline plasma increments after oral loads were similar in LPI homozygotes and controls, unlike diamino-acid increments.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/citrulline-research/6776014.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6db6a42e66322b8ae26335a4f51284ede7691dcbb91e8cf7d7cd6671bd41b87d", "start_char": 0, "end_char": 1189, "text_sha256": "6db6a42e66322b8ae26335a4f51284ede7691dcbb91e8cf7d7cd6671bd41b87d"}
- experimental_model
- Oral amino-acid loading comparison
- exposure
- Separate diamino-acid and citrulline loads
- limitations
- Inherited transport disorder, not ordinary competition from mixed dietary protein; the study predates gene identification.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human LPI patients, heterozygotes and controls
- plain_language
- A different entry route can bypass this particular transport problem.
- primary_references
- [citrulline-p6776014] Intestinal absorption in lysinuric protein intolerance: impaired for diamino acids, normal for citrulline. (1980). https://pubmed.ncbi.nlm.nih.gov/6776014/ DOI: 10.1136/gut.21.6.519
- tissue_or_cell_type
- Intestinal amino-acid absorption inferred from plasma and urine
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 840–851
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Oral amino-acid loading comparison · source_derived_draft · unverified_draft
### citrulline-lpi-citrulline-absorption Citrulline plasma increments after oral loads were similar in LPI homozygotes and controls, unlike diamino-acid increments. Condition category: machinery_impairment nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: A different entry route can bypass this particular transport problem. organism: Human LPI patients, heterozygotes and controls tissue_or_cell_type: Intestinal amino-acid absorption inferred from plasma and urine experimental_model: Oral amino-acid loading comparison limitations: Inherited transport disorder, not ordinary competition from mixed dietary protein; the study predates gene identification. exposure: Separate diamino-acid and citrulline loads evidence_span: {"source_cache": "artifacts/citrulline-research/6776014.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6db6a42e66322b8ae26335a4f51284ede7691dcbb91e8cf7d7cd6671bd41b87d", "start_char": 0, "end_char": 1189, "text_sha256": "6db6a42e66322b8ae26335a4f51284ede7691dcbb91e8cf7d7cd6671bd41b87d"} [citrulline-p6776014] Intestinal absorption in lysinuric protein intolerance: impaired for diamino acids, normal for citrulline. (1980). https://pubmed.ncbi.nlm.nih.gov/6776014/ DOI: 10.1136/gut.21.6.519
Complete structured claim and evidenceCarnosine also inhibited protein modification caused by products formed by incubating lysine with methylglyoxal.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cell-free lysine-MG AGE preparation.
- limitations
- The study does not demonstrate removal of established tissue AGE deposits.
- nutrient_topic
- Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
- plain_language
- Protection was tested against secondary reaction products too.
- primary_references
- Carnosine protects proteins against methylglyoxal-mediated modifications. · 1998 · https://pubmed.ncbi.nlm.nih.gov/9675080/ · DOI 10.1006/bbrc.1998.8806
Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 260–266
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Cell-free lysine-MG AGE preparation. · source_derived_draft · unverified_draft
## carnosine-mg-secondary Protection was tested against secondary reaction products too. Carnosine also inhibited protein modification caused by products formed by incubating lysine with methylglyoxal. Model: Cell-free lysine-MG AGE preparation. Limitations: The study does not demonstrate removal of established tissue AGE deposits. Evidence access: Primary abstract Carnosine protects proteins against methylglyoxal-mediated modifications. · 1998 · https://pubmed.ncbi.nlm.nih.gov/9675080/ · DOI 10.1006/bbrc.1998.8806
Complete structured claim and evidenceSelective AASS saccharopine-dehydrogenase impairment while reductase activity persists causes saccharopine accumulation.
Experimental context and source evidence
- affected_machinery
- AASS saccharopine dehydrogenase
- availability_state
- machinery_impairment Imported condition classification; unverified.
- deficiency_not_equivalent
- Dietary lysine deficiency or complete AASS knockout
- experimental_model
- AASS-domain mutant worms and engineered mice
- limitations
- Selective downstream-domain failure differs from complete AASS loss.
- organism
- Caenorhabditis elegans and Mus musculus
- plain_language
- Saccharopine builds up when its production continues but its removal fails.
- primary_references
- [zhou2019] The lysine catabolite saccharopine impairs development by disrupting mitochondrial homeostasis (2019). https://pmc.ncbi.nlm.nih.gov/articles/PMC6363459/ DOI: 10.1083/jcb.201807204
- tissue_or_cell_type
- Worm hypodermis and mouse liver
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 230–240
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · AASS-domain mutant worms and engineered mice · source_derived_draft · unverified_draft
### aass-sdh-saccharopine-accumulation Selective AASS saccharopine-dehydrogenase impairment while reductase activity persists causes saccharopine accumulation. Plain language: Saccharopine builds up when its production continues but its removal fails. Condition category: machinery_impairment organism: Caenorhabditis elegans and Mus musculus tissue_or_cell_type: Worm hypodermis and mouse liver experimental_model: AASS-domain mutant worms and engineered mice limitations: Selective downstream-domain failure differs from complete AASS loss. affected_machinery: AASS saccharopine dehydrogenase deficiency_not_equivalent: Dietary lysine deficiency or complete AASS knockout [zhou2019] The lysine catabolite saccharopine impairs development by disrupting mitochondrial homeostasis (2019). https://pmc.ncbi.nlm.nih.gov/articles/PMC6363459/ DOI: 10.1083/jcb.201807204
Complete structured claim and evidenceE. coli CadB couples lysine uptake to cadaverine export in the Cad acid-response system.
Experimental context and source evidence
- experimental_model
- E. coli cells and membrane vesicles expressing CadB; cadaverine uptake/excretion and lysine exchange assays.
- limitations
- Bacterial antiport, not the mammalian intestinal lysine transporter or a clinical dysbiosis claim.
- organism
- Escherichia coli
- plain_language
- Transport connects extracellular lysine with bacterial cadaverine release.
- primary_references
- [cadb-2004] Excretion and uptake of cadaverine by CadB and its physiological functions in Escherichia coli (2004). https://pubmed.ncbi.nlm.nih.gov/14982633/ DOI: 10.1046/j.1365-2958.2003.03913.x
- tissue_or_cell_type
- Not specified as a whole tissue; see experimental model.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 628–636
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · E. coli cells and membrane vesicles expressing CadB; cadaverine uptake/excretion and lysine exchange assays. · source_derived_draft · unverified_draft
### bacterial-cadb-exchange E. coli CadB couples lysine uptake to cadaverine export in the Cad acid-response system. Plain language: Transport connects extracellular lysine with bacterial cadaverine release. Condition category: normal organism: Escherichia coli tissue_or_cell_type: Not specified as a whole tissue; see experimental model. experimental_model: E. coli cells and membrane vesicles expressing CadB; cadaverine uptake/excretion and lysine exchange assays. limitations: Bacterial antiport, not the mammalian intestinal lysine transporter or a clinical dysbiosis claim. [cadb-2004] Excretion and uptake of cadaverine by CadB and its physiological functions in Escherichia coli (2004). https://pubmed.ncbi.nlm.nih.gov/14982633/ DOI: 10.1046/j.1365-2958.2003.03913.x
Complete structured claim and evidenceDHTKD1-deficient patient fibroblasts accumulate lysine-derived 2-oxoadipate; wild-type complementation restores its disposal.
Experimental context and source evidence
- affected_machinery
- Oxoadipate-dehydrogenase E1
- availability_state
- machinery_impairment Imported condition classification; unverified.
- deficiency_not_equivalent
- Dietary lysine deficiency
- experimental_model
- Two human patients and isotope-traced fibroblasts
- limitations
- Biochemical causation is stronger than attribution of every neurological finding.
- organism
- Homo sapiens
- plain_language
- A downstream enzyme defect leaves oxoadipate uncleared.
- primary_references
- [danhauser2012] DHTKD1 mutations cause 2-aminoadipic and 2-oxoadipic aciduria (2012). https://pmc.ncbi.nlm.nih.gov/articles/PMC3516599/ DOI: 10.1016/j.ajhg.2012.10.006
- tissue_or_cell_type
- Fibroblasts; clinical aciduria
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 278–288
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Two human patients and isotope-traced fibroblasts · source_derived_draft · unverified_draft
### dhtkd1-oxoadipate-accumulation DHTKD1-deficient patient fibroblasts accumulate lysine-derived 2-oxoadipate; wild-type complementation restores its disposal. Plain language: A downstream enzyme defect leaves oxoadipate uncleared. Condition category: machinery_impairment organism: Homo sapiens tissue_or_cell_type: Fibroblasts; clinical aciduria experimental_model: Two human patients and isotope-traced fibroblasts limitations: Biochemical causation is stronger than attribution of every neurological finding. affected_machinery: Oxoadipate-dehydrogenase E1 deficiency_not_equivalent: Dietary lysine deficiency [danhauser2012] DHTKD1 mutations cause 2-aminoadipic and 2-oxoadipic aciduria (2012). https://pmc.ncbi.nlm.nih.gov/articles/PMC3516599/ DOI: 10.1016/j.ajhg.2012.10.006
Complete structured claim and evidenceHigh lysine intake in Gcdh-null mice increases glutarate accumulation and produces age-dependent brain injury.
Experimental context and source evidence
- affected_machinery
- GCDH
- availability_state
- machinery_impairment Imported condition classification; unverified.
- deficiency_not_equivalent
- Nutrient deficiency or normal human lysine intake
- experimental_model
- High-lysine dietary challenge of Gcdh-knockout mice
- limitations
- Genetic susceptibility and age are essential; does not show comparable toxicity in healthy humans.
- organism
- Mus musculus
- plain_language
- Lysine loading can worsen a blocked breakdown pathway.
- primary_references
- [zinnanti2006] A diet-induced mouse model for glutaric aciduria type I (2006). https://pubmed.ncbi.nlm.nih.gov/16446282/ DOI: 10.1093/brain/awl009
- tissue_or_cell_type
- Brain and systemic circulation
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 290–300
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · High-lysine dietary challenge of Gcdh-knockout mice · source_derived_draft · unverified_draft
### gcdh-high-lysine-glutarate High lysine intake in Gcdh-null mice increases glutarate accumulation and produces age-dependent brain injury. Plain language: Lysine loading can worsen a blocked breakdown pathway. Condition category: machinery_impairment organism: Mus musculus tissue_or_cell_type: Brain and systemic circulation experimental_model: High-lysine dietary challenge of Gcdh-knockout mice limitations: Genetic susceptibility and age are essential; does not show comparable toxicity in healthy humans. affected_machinery: GCDH deficiency_not_equivalent: Nutrient deficiency or normal human lysine intake [zinnanti2006] A diet-induced mouse model for glutaric aciduria type I (2006). https://pubmed.ncbi.nlm.nih.gov/16446282/ DOI: 10.1093/brain/awl009
Complete structured claim and evidenceAfter resistance exercise, 20 g highly glycated milk protein yielded lower six-hour plasma lysine availability than less glycated protein in young men; both protein arms also received 2 g free leucine.
Experimental context and source evidence
- experimental_model
- Randomized parallel trial in 45 healthy young men comparing 20 g high-glycation milk protein plus 2 g free leucine, 20 g low-glycation milk protein plus 2 g free leucine, and noncaloric placebo
- limitations
- Both protein arms included 2 g free leucine. Processing-related protein modification was manipulated; this was not a free-lysine supplementation or anti-glycation treatment trial.
- organism
- Homo sapiens
- plain_language
- Chemical modification of food protein changed how much lysine appeared in circulation.
- primary_references
- [vanlieshout2025] Milk Protein Glycation Compromises Postprandial Lysine Bioavailability but does not Modulate Postprandial Muscle Protein Synthesis Rates In Vivo in Males: A Double-blind, Randomized Parallel Trial (2025). https://pmc.ncbi.nlm.nih.gov/articles/PMC12308134/ DOI: 10.1016/j.tjnut.2025.05.032
- tissue_or_cell_type
- Blood after feeding
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 799–807
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized parallel trial in 45 healthy young men comparing 20 g high-glycation milk protein plus 2 g free leucine, 20 g low-glycation milk protein plus 2 g free leucine, and noncaloric placebo · source_derived_draft · unverified_draft
### milk-glycation-lysine-availability After resistance exercise, 20 g highly glycated milk protein yielded lower six-hour plasma lysine availability than less glycated protein in young men; both protein arms also received 2 g free leucine. Plain language: Chemical modification of food protein changed how much lysine appeared in circulation. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Blood after feeding experimental_model: Randomized parallel trial in 45 healthy young men comparing 20 g high-glycation milk protein plus 2 g free leucine, 20 g low-glycation milk protein plus 2 g free leucine, and noncaloric placebo limitations: Both protein arms included 2 g free leucine. Processing-related protein modification was manipulated; this was not a free-lysine supplementation or anti-glycation treatment trial. [vanlieshout2025] Milk Protein Glycation Compromises Postprandial Lysine Bioavailability but does not Modulate Postprandial Muscle Protein Synthesis Rates In Vivo in Males: A Double-blind, Randomized Parallel Trial (2025). https://pmc.ncbi.nlm.nih.gov/articles/PMC12308134/ DOI: 10.1016/j.tjnut.2025.05.032
Complete structured claim and evidencePathogenic SLC7A7 variants impair epithelial dibasic-amino-acid transport in lysinuric protein intolerance.
Experimental context and source evidence
- affected_machinery
- SLC7A7-containing transporter
- availability_state
- machinery_impairment Imported condition classification; unverified.
- deficiency_not_equivalent
- Dietary lysine deficiency
- experimental_model
- Human inherited disease genetics and transport characterization
- limitations
- A multiamino-acid transport disorder; systemic manifestations are not attributable solely to dietary lysine shortage.
- organism
- Homo sapiens
- plain_language
- A transport defect can limit lysine delivery despite its presence in food.
- primary_references
- [torrents1999] Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene (1999). https://www.nature.com/articles/ng0399_293 DOI: 10.1038/6809
- tissue_or_cell_type
- Intestinal and renal epithelial basolateral membranes
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 218–228
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human inherited disease genetics and transport characterization · source_derived_draft · unverified_draft
### slc7a7-lpi Pathogenic SLC7A7 variants impair epithelial dibasic-amino-acid transport in lysinuric protein intolerance. Plain language: A transport defect can limit lysine delivery despite its presence in food. Condition category: machinery_impairment organism: Homo sapiens tissue_or_cell_type: Intestinal and renal epithelial basolateral membranes experimental_model: Human inherited disease genetics and transport characterization limitations: A multiamino-acid transport disorder; systemic manifestations are not attributable solely to dietary lysine shortage. affected_machinery: SLC7A7-containing transporter deficiency_not_equivalent: Dietary lysine deficiency [torrents1999] Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene (1999). https://www.nature.com/articles/ng0399_293 DOI: 10.1038/6809
Complete structured claim and evidenceAmino-acid loading experiments indicated inhibition of renal citrulline transport by arginine, lysine and ornithine.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Nine men in oral lysine tests; three men in intravenous amino-acid loading tests.
- limitations
- Small historical experiment; no molecular transporter identified and no ordinary-meal effect size established.
- nutrient_topic
- L-Arginine collection; tissue, species, dose and formulation distinctions retained. · L-Arginine
- plain_language
- Related amino acids interacted at a kidney transport step.
- primary_references
- A new transport interaction of dibasic amino acids and citrulline in human kidney. · 1981 · https://pubmed.ncbi.nlm.nih.gov/6797099/ · DOI 10.1620/tjem.134.55
L-Arginine: transport, metabolic branches, nutrient interactions, availability and discovery questions (2026-09-18) · lines 54–60
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Nine men in oral lysine tests; three men in intravenous amino-acid loading tests. · source_derived_draft · unverified_draft
## arg-renal-competition Related amino acids interacted at a kidney transport step. Amino-acid loading experiments indicated inhibition of renal citrulline transport by arginine, lysine and ornithine. Model: Nine men in oral lysine tests; three men in intravenous amino-acid loading tests. Limitations: Small historical experiment; no molecular transporter identified and no ordinary-meal effect size established. Evidence access: Primary abstract A new transport interaction of dibasic amino acids and citrulline in human kidney. · 1981 · https://pubmed.ncbi.nlm.nih.gov/6797099/ · DOI 10.1620/tjem.134.55
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.